At the end of 2016 Dr Calbi, an Italian hematologist who had been working at Lacor hospital and played a major role in both the coordination and documentation of data collected in the course of the Burkitt lymphoma study supported by INCTR and OFID (OPEC Fund For INTERNATIONAL Developmentt) returned to Italy after several years in Uganda where sh was chief of the Pediatric Cancer department. She was involved in all aspects of the study, which covered access to care, treatment and follow-up. She also assisted with data collection and management. Her efforts to improve survival bore fruit: in a case series of 118 patients, survival rate was 71%. The data was analysed with the help of an expert statistitican and presented at Lugano in June 2016.